Dead Cat Bounce, the slide will continue...to think that the world money markets are stable, would reflect the view of a fool.
Choices, do I pull my stop-loss placements, do I buy more BRN, do I hope that the 4C delivers similar revenue to the previous quarter,
do I believe "explosive sales" are wrapped up in the coming 4C results or the results to be published in late January....so many thoughts
one can have.
Carrying no debt, having cash on hand is a major positive, especially in times of uncertainty, and that's Brainchip down to a tee.
How's Magik Eye Inc going? (August 2020) 2 years 2 months, any word?
We have ALL been on a learning curve, including the company executives over many years, I have already penned 2025 as the year,
hopefully things ramp up prior to 2025, but for me, that's my current assessment, based on nothing to do with the technology, but
everything else that circles us, the financial markets, ideas to product conversion, continuous education of potential clients, building
positive partnerships with key world players that can blossom into the future, to me it's really come down to the time factor, which I
nor you or for that matter, even the company can control.
I notice DIGIMARC has had another patent granted, Brainchip's Akida is still mentioned, but so are other processors.
I'd keep checking patents regularly, they are worth their weight in gold, in my opinion moving forward.
Cheers and goodnight...Tech
Hi Tech,
It's getting on for 2 years since the announcement of the Renesas agreement.
The blurb on the Renesas agreement says:
Aliso Viejo, Calif. – 23 December 2020 – B
rainChip Holdings Ltd (ASX: BRN), a leading provider of ultra-low power, high-performance AI technology, today announced the signing of an intellectual property license agreement with Renesas Electronics America Inc., a subsidiary of Japan-based Renesas Electronics Corp., a tier-one semiconductor manufacturer that specializes in microcontroller and automotive SoC products. The unconditional agreement provides for:
• a single-use, royalty-bearing, worldwide IP design license for the rights to use the Akida™ IP in the customer’s SoC products, which continues while the customer continues to use the Akida IP in its products. The parties agreed to customary termination terms;
• BrainChip to provide implementation support services (at an agreed fee to cover costs) aimed at facilitating the customer’s adoption and commercialization of the Akida-licensed product during the first year of the license agreement.
• The agreement provides for various payment terms including the payment of ongoing royalties based on the volume of units sold, commencing at certain agreed volume threshold and the net sale price of the customer’s products. The royalties remain in effect throughout the life of the licensed product.
• Brainchip to provide software maintenance services, which attract a separate fee if the customer elects to continue to use these services after the first two years of the agreement.
So we won't see any royalties from Renesas until there are units sold.
As Renesas is an automotive supplier, their products would need to undergo extensive testing, particularly if they are safety related. Also Renesas is a big company with a large number of products, so getting what may be a relatively minor product to market may not be critical to their commercial viability.
Late edition: Also Renesas has their own in-house DRP-AI which, it seems, they are giving preference to in larger AI applications.
As for the MegaChips partnership, announced 10 months ago, we appear to have received the initial licence fees for at least a couple of licences in the mid-year report.
MegaChips is a different business model from Renesas, as they design products at the behest of 3rd parties, whereas Renesas designs their own products.
We don't know the nature of the businesses of the licencees, so it's difficult to judge when we can expect royalties from the MegaChip licencees.
However, it may be assumed that some of the MC customers are smaller than Renesas and with a more limited product range, so getting a new product out the door could have a significant effect on their bottom line. Also their products may not be as critical to safety as many Renesas products, so testing may not need to be as extensive.
Of course there is the extensive task of getting the chip designed, manufactured and approved, but since the Akida IP has been proven in silicon, the Akida IP should not provide too many holdups in this process.
Thus, once the smaller companies pay the licence fee, they would be anxious to get the product out the door, so the licence money is not sitting idle for too long. So I'm hoping that we see royalties from the MegaChip licencees sooner rather than later.
